Abstract
Sir, I read with interest the article by Ross et al[1][1] in the June 2007 issue entitled ‘Survival and clinical outcome of SB Charite III disc replacement for back pain’ and feel that this study is, at best, level V evidence. However, methodological flaws fail to make this a clinically
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
